Percutaneous transluminal coronary angioplasty

Area of Science:

• Cardiology
• Interventional Cardiology
• Vascular Medicine

Background:

• Coronary atherosclerosis is a leading cause of angina pectoris.
• Percutaneous transluminal coronary angioplasty (PTCA) emerged in 1977 as an alternative to surgical intervention.
• Patient selection is crucial for successful PTCA outcomes.

Purpose of the Study:

• To evaluate the efficacy and safety of PTCA in selected patients with coronary atherosclerosis.
• To assess the success rates, symptomatic improvement, and long-term patency following PTCA.
• To determine complication rates, including the need for urgent coronary artery bypass graft surgery.

Main Methods:

• Review of clinical experience with PTCA in patients with angina pectoris.
• Identification of ideal patient candidates based on lesion characteristics (proximal, noncalcified, discrete, tapered stenosis).
• Utilizing objective evidence of coronary insufficiency (scintigraphy, exercise testing) for patient selection and follow-up.

Main Results:

• Successful dilation of coronary stenoses achieved in 60%-85% of selected patients.
• Symptomatic improvement reported in nearly 90% of successful PTCA procedures.
• Persistent vessel patency observed for over 1 year post-procedure.
• Urgent coronary artery bypass graft surgery required in 3%-8% of patients due to complications.
• Mortality rate associated with PTCA is less than 1%.

Conclusions:

• PTCA is an effective and relatively safe procedure for selected patients with angina due to coronary atherosclerosis.
• The procedure offers significant symptomatic relief and maintains vessel patency in the majority of patients.
• Further data compilation is necessary to refine patient selection criteria and understand long-term results.